Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Aug 6th, 6:31 PM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | 25.15 - 31.77 |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
Solid Power (SLDP) Q2 2025 earnings beat estimates with $7.5M revenue, narrower EPS loss. BMW and SK On partnerships advance solid-state battery tech. Shares rise cautiously.
Via Chartmill · August 6, 2025
HeartBeam Inc. (NASDAQ: BEAT) FDA-Cleared System Provides Momentum as Company Moves to Innovate Cardiac Care
Foundational clearance from the U.S. Food and Drug Administration (“FDA”) for its patented HeartBeam system has proved pivotal for HeartBeam (NASDAQ: BEAT), a cardiac technology company focused on transforming the cardiac-care space ( https://ibn.fm/0TAG4 ). The first cable-free, high-fidelity ECG device that captures the heart’s electrical activity from three distinct directions, the HeartBeam system enables patients and physicians to access critical arrhythmia data outside traditional clinical settings.
Via Investor Brand Network · August 6, 2025
Nutriband Inc. (NASDAQ: NTRB) Navigates Drug-Delivery Challenges with Innovation in Abuse-Deterrent Tech
Developing safe, effective and abuse-deterrent delivery systems for controlled substances such as fentanyl is a formidable challenge, and Nutriband (NASDAQ: NTRB) is positioning itself at the forefront of that effort. The company is pioneering transdermal technologies to deliver medications that require careful balancing of patient access with strong mitigation against misuse.
Via Investor Brand Network · August 6, 2025
Humanoid robots, once confined to the realm of science fiction, are rapidly transitioning into tangible products available for purchase. While the market is still in its nascent stages, these advanced machines are finding diverse applications, ranging from industrial automation and cutting-edge research to educational tools and even emerging consumer-grade personal
Via MarketMinute · August 6, 2025
Dallas, TX - August 6, 2025 - Dallas has a new destination for European auto enthusiasts who demand more from their repair, detailing, and performance experience. GB Motors, located at 11444 N Stemmons Fwy, is now open and raising the bar for European car care across the Dallas–Fort Worth metroplex.
Via Get News · August 6, 2025
HeartBeam Inc.’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics
HeartBeam (NASDAQ: BEAT), a cardiac technology company, has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology ( https://ibn.fm/6xni4 ). The company, focused on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform, now holds more than 20 U.S. and international patents, with additional applications pending.
Via Investor Brand Network · August 5, 2025
Study Finds That Inflammation Markers in Diabetics Influence Depression Treatment Outcomes
On average, diabetics tend to suffer from depression at higher rates than is seen in the general population. A new study conducted by a team at the German Diabetes Center and other institutions in Germany has found that the markers of chronic inflammation influence how successful the treatments provided for depression will be for patients living with diabetes.
Via Investor Brand Network · August 5, 2025
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and MS, announced that its management will present at the Canaccord 45th Annual Growth Conference and participate in one-on-one investor meetings.
Via Investor Brand Network · August 5, 2025
BioMedNewsBreaks — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Market Demand for Breast CT Imaging Innovation
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and the advantages of its IzoView Breast CT Imaging System. With over 2.3 million new cases of breast cancer diagnosed worldwide annually and U.S. incidence projected to exceed 315,000 in 2025, healthcare systems face growing pressure to improve screening outcomes. Market forecasts show global breast imaging revenues rising from $5.4 billion in 2024 to $8.69 billion by 2030. IzoView addresses clinical and patient needs with non-compressive 3D imaging, offering a more comfortable, accurate, and scalable alternative to conventional modalities—especially for the 50% of women with dense breast tissue.
Via Investor Brand Network · August 5, 2025
Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone
Obtaining approval from the U.S. Food and Drug Administration (“FDA”) is a monumental achievement for any biopharmaceutical company, serving as a critical validation of a drug’s safety and efficacy. This rigorous process is a cornerstone of public health, ensuring that only treatments proven to be beneficial and with acceptable risks reach patients. Recognizing the immense value this milestone represents, Nutriband (NASDAQ: NTRB) recently underscored its commitment to this pathway by announcing a 25% preferred stock dividend as the company targets filing for FDA approval for its lead product, AVERSA(TM) Fentanyl ( https://ibn.fm/8FRUA ).
Via Investor Brand Network · August 5, 2025
Mordor Intelligence has published a new report on the Luxury EV Market offering a comprehensive analysis of trends, growth drivers, and future projections
Via Press Release Distribution Service · August 5, 2025
The global automotive industry is currently navigating a period of profound transformation, marked by groundbreaking strategic shifts, evolving market dynamics, and significant leadership changes. Recent developments, including a colossal new pay package for Tesla (NASDAQ: TSLA) CEO Elon Musk tied to the company's ambitious robotaxi and humanoid robot ventures, the
Via MarketMinute · August 4, 2025
Irvine, Calif. – Modern Elite Transportation, a trusted name in executive ground travel since 2010, has launched a redesigned website that reflects its growing role as a mobility partner to professionals, event organizers, and institutions requiring precision and discretion. With operations centered in Southern California and now expanding globally, the company continues to embody its mission: Moving Those Who Move the World .
Via GetFeatured · August 4, 2025
Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment
Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams could rely on to predict which patients having glioblastoma stand higher chances of benefiting from bevacizumab, a cancer drug.
Via Investor Brand Network · August 1, 2025
BMW Group commenced its San Luis Potosí plant expansion in Mexico, with Jilian Group serving as the lead electromechanical engineering contractor. The expansion project in Mexico recently held its groundbreaking ceremony. Senior executives from Jilian joined BMW Mexico’s management team in witnessing this strategic milestone.
Via Binary News Network · August 1, 2025
New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
Computer scientists have designed an AI-based speech screening tool that could help people ascertain whether they could be exhibiting signs of Parkinson’s . The research explaining this speech tool appeared in the npj Parkinson’s Disease journal.
Via Investor Brand Network · July 31, 2025
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company will also provide updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. CEO Robert Eno and CFO Timothy Cruickshank will host the call, followed by a question-and-answer session.
Via Investor Brand Network · July 30, 2025
QuantumScape Corporation (NYSE:QS), a leading developer of solid-state lithium-metal batteries for electric vehicles, saw its shares drop sharply following its latest earnings announcement. The decline reflects growing investor concern over the company’s financial performance, delayed commercialization roadmap, and heightened competition in the solid-state battery space.
Post-Earnings Stock Reaction
Via MarketMinute · July 29, 2025
Why Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Is ‘One to Watch’
Izotropic (CSE: IZO) (OTCQB: IZOZF) is a medical device company advancing dedicated imaging solutions to improve the screening, diagnosis, and treatment of breast cancer. Focused exclusively on this clinical area, Izotropic is developing purpose-built technologies designed to address persistent limitations in conventional breast imaging. Through innovation in both device architecture and image acquisition, the company aims to enhance diagnostic confidence while improving patient experience.
Via Investor Brand Network · July 29, 2025
Study Discovers That Autoantibodies in Patients Could Boost Cancer Immunotherapy
For years, oncologists have been baffled by why checkpoint inhibitors work for some cancer patients and not others. This challenge has made it difficult for these immunotherapies to be widely used since it isn’t easy to predict who will benefit and yet the treatments are currently very expensive .
Via Investor Brand Network · July 29, 2025
The move comes as Harley braces for a challenging year, with mounting tariff costs, a pending CEO transition, and efforts to attract younger riders with more affordable models.
Via Stocktwits · July 28, 2025
Las Vegas, Nevada - SmartTOP manufacturer Mods4cars has announced a permanent price reduction for its SmartTOP convertible top control module for Volkswagen Beetle Convertible. The retrofittable SmartTOP module is now available for 149.00 Euros plus tax. “We’re pleased that even more VW Beetle drivers can now enjoy the benefits of our feature-rich upgrade,” says PR spokesperson Sven Tornow.
Via Get News · July 28, 2025
Libertyville, IL () July 28, 2025 -- Expert BMW maintenance at Auto Lab Libertyville redefines luxury vehicle care for local drivers
Via Prodigy · July 28, 2025
BioMedNewsBreaks — HealthLynked Corp. (OTCQB: HLYK) Launches Enterprise Healthcare Solutions Website and Upgrades Provider Directory
HealthLynked (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, announced the launch of its newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com , and significant enhancements to its national provider directory. The new platform serves as a centralized hub for insurance carriers, pharmaceutical companies, marketing firms, ACOs, healthcare networks, and large employers, offering tools for patient engagement, population health, clinical research, coordinated care, and cost management. Upgrades to the consumer-facing provider directory include faster performance and localized provider suggestions, giving patients improved flexibility and transparency in selecting care. CEO Dr. Michael Dent said the developments reflect HealthLynked’s expanding role in the healthcare ecosystem and its commitment to scalable solutions that improve outcomes and reduce costs.
Via Investor Brand Network · July 28, 2025